PMID: 6105244Jul 12, 1980Paper

Cancer research campaign (King's/Cambridge) trial for early breast cancer. A detailed update at the tenth year. Cancer Research Campaign Working Party

Lancet

Abstract

In the tenth year of follow-up of a multicentre trial of the management of operable breast cancer no significant difference in survival was found between patients treated with simple mastectomy alone (with radiotherapy later if the disease recurred) and those treated with simple mastectomy and routine immediate postoperative radiotherapy. There was a highly significant increased risk of local recurrence in the conservatively treated group, with a hazard ratio of 3.0. The biological and clinical relevance of these results is discussed.

Citations

Oct 1, 1985·World Journal of Surgery·B Fisher
Mar 1, 1989·Breast Cancer Research and Treatment·A W LeesJ Hanson
Jan 1, 1996·Breast Cancer Research and Treatment·M NoguchiI Miyazaki
Jan 1, 1985·Breast Cancer Research and Treatment·J R Harris, R T Osteen
Sep 5, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Masakuni Noguchi
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·A TsuchiyaI Kimijima
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M NoguchiA Nonomura
Oct 13, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M NoguchiK Tsugawa
Aug 28, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Masakuni Noguchi
Aug 28, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A MilletF Dirbas
Jan 26, 1991·Lancet·I S Fentiman, R E Mansel
Dec 13, 2000·American Journal of Surgery·J E GervasoniB Cady
Nov 26, 1999·The Surgical Clinics of North America·I Jatoi
Jan 5, 2001·The Surgical Clinics of North America·J E GervasoniB Cady
Aug 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J R Harris, S Hellman
Feb 16, 2000·European Journal of Radiology·H J De Koning
Apr 18, 1998·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J WinehouseM Baum
May 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D A L MorganR W Blamey
Jul 31, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G CserniUNKNOWN European Working Group for Breast Screening Pathology
Jan 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K MacRae
Feb 5, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U VeronesiR Zucali
Dec 22, 1999·Breast Cancer Research and Treatment·M NoguchiA Nonomura
Nov 18, 2000·Breast Cancer Research and Treatment·M NoguchiK Tsugawa
Dec 5, 2002·Breast Cancer Research and Treatment·Masakuni Noguchi
Aug 1, 1984·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J R Yarnold
Feb 8, 2005·The Breast : Official Journal of the European Society of Mastology·T OwakiT Aikou
May 9, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony LucciUNKNOWN American College of Surgeons Oncology Group
Sep 24, 1999·Occupational and Environmental Medicine·D BarisS Wacholder
Mar 1, 1988·British Journal of Industrial Medicine·M Rossignol, G Thériault
Aug 1, 1987·British Journal of Industrial Medicine·J C McDonaldA D McDonald
Apr 1, 1996·Occupational and Environmental Medicine·A M Stewart, G W Kneale
Oct 4, 2018·Journal of Neurology, Neurosurgery, and Psychiatry·Silvan LicherM Arfan Ikram
Jan 22, 2010·Journal of Cancer Research and Clinical Oncology·LingLing PanHuang Gang
Apr 29, 2006·European Journal of Cancer Care·S Maslin-Prothero
Jan 1, 1989·American Journal of Industrial Medicine·C J HullS Preston-Martin
Jan 1, 1993·International Journal of Technology Assessment in Health Care·S KlawanskyT C Chalmers
Mar 3, 2012·World Journal of Surgery·Ismail Jatoi
Jun 1, 1993·British Heart Journal·D Sebag-Montefiore, H Hope-Stone
Aug 20, 1988·BMJ : British Medical Journal·J F RobertsonR W Blamey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.